Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gluzman

Showing results (151-160 of 246) with videos related to

Pageof 25
Sort By:
Bioorganic & Medicinal Chemistry|September 6, 2002
Novel and potent anti-malarial agentsKristin M Brinner, Jin Mi Kim, Hiromu Habashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2011
Validation of isoleucine utilization targets in Plasmodium falciparumEva S Istvan, Neekesh V Dharia, Selina E Bopp, et al.
Molekuliarnaia Biologiia|May 1, 1994
[Inhibitory analysis of DNA polymerases from human viruses using modified substrates]M K Kukhanova, E V Kuznetsova, A A Kraevskiĭ, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigenI J Mohr, Y Gluzman, M P Fairman, et al.
International Journal of Cardiology|May 30, 2001
Combined leukocyte and erythrocyte aggregation in patients with acute myocardial infarctionI Shapira, R Rotstein, R Fusman, et al.
The Journal of Infectious Diseases|December 1, 1984
Clindamycin activity against chloroquine-resistant Plasmodium falciparumL S Seaberg, A R Parquette, I Y Gluzman, et al.
Experimental Oncology|June 27, 2015
Overview on association of different types of leukemias with radiation exposureD F Gluzman, L M Sklyarenko, M P Zavelevich, et al.
Exploration of Targeted Anti-Tumor Therapy|April 4, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinomaIlya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, et al.
Molekuliarnaia Biologiia|July 1, 1994
[Inhibitory analysis of DNA polymerase of herpes simplex type 1]M K Kukhanova, E V Kuznetsova, M V Ias'ko, et al.
Neoplasma|January 1, 1992
Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotypingS P Sidorenko, E P Vetrova, O V Yurchenko, et al.
Pageof 25

Showing results (151-160 of 246) with videos related to

Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry|September 6, 2002
Novel and potent anti-malarial agentsKristin M Brinner, Jin Mi Kim, Hiromu Habashita, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2011
Validation of isoleucine utilization targets in Plasmodium falciparumEva S Istvan, Neekesh V Dharia, Selina E Bopp, et al.
Molekuliarnaia Biologiia|May 1, 1994
[Inhibitory analysis of DNA polymerases from human viruses using modified substrates]M K Kukhanova, E V Kuznetsova, A A Kraevskiĭ, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigenI J Mohr, Y Gluzman, M P Fairman, et al.
International Journal of Cardiology|May 30, 2001
Combined leukocyte and erythrocyte aggregation in patients with acute myocardial infarctionI Shapira, R Rotstein, R Fusman, et al.
The Journal of Infectious Diseases|December 1, 1984
Clindamycin activity against chloroquine-resistant Plasmodium falciparumL S Seaberg, A R Parquette, I Y Gluzman, et al.
Experimental Oncology|June 27, 2015
Overview on association of different types of leukemias with radiation exposureD F Gluzman, L M Sklyarenko, M P Zavelevich, et al.
Exploration of Targeted Anti-Tumor Therapy|April 4, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinomaIlya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, et al.
Molekuliarnaia Biologiia|July 1, 1994
[Inhibitory analysis of DNA polymerase of herpes simplex type 1]M K Kukhanova, E V Kuznetsova, M V Ias'ko, et al.
Neoplasma|January 1, 1992
Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotypingS P Sidorenko, E P Vetrova, O V Yurchenko, et al.
Pageof 25